儿童重症监护输血与贫血专家倡议:非危及生命出血或失血性休克危重患儿红细胞输注建议
儿童重症监护输血与贫血专家倡议通过共识会议制定危重患儿急性出血的红细胞输注建议,38名国际多学科专家参与,出血亚组5名专家,检索PubMed、EMBASE和Cochrane Library(1980年至2017年5月),采用RAND/UCLA适宜性方法和GRADE分级。共形成6条建议:非危及生命出血时血红蛋白<5 g/dL推荐输注红细胞,5–7 g/dL可考虑输注;失血性休克时建议红细胞、血浆和血小板比例2:1:1至1:1:1直至出血不再危及生命。工作组还提出未来研究方向,包括开发生理和实验室指标指导输血、确定目标导向止血复苏是否改善生存,以及比较低滴度O型全血与重组全血在儿童失血性休克中的有效性和安全性。
要点
- 非危及生命出血的危重患儿:血红蛋白<5 g/dL推荐输注红细胞;血红蛋白5–7 g/dL可考虑输注。
- 失血性休克的危重患儿:建议红细胞、血浆和血小板按2:1:1至1:1:1比例输注,直至出血不再危及生命。
- 推荐未来研究开发生理和实验室指标以指导红细胞输注需求。
- 推荐未来研究确定目标导向止血复苏是否改善生存。
- 推荐未来研究确定低滴度O型全血是否比重组全血更有效和安全。
适用人群与场景
- 危重患儿,包括非危及生命出血和失血性休克两种情况。
诊断标准与关键阈值
- 非危及生命出血:血红蛋白浓度<5 g/dL推荐输注红细胞;血红蛋白浓度5–7 g/dL可考虑输注红细胞。
处置流程与药物剂量
- 非危及生命出血:血红蛋白<5 g/dL时输注红细胞;血红蛋白5–7 g/dL时可考虑输注红细胞。
- 失血性休克:建议红细胞、血浆和血小板输注比例在2:1:1至1:1:1之间,直至出血不再危及生命。
研究设计与关键结果
- 共识会议共形成6条建议,聚焦危重患儿急性出血的输血管理。
- 非危及生命出血:血红蛋白<5 g/dL推荐输注红细胞,5–7 g/dL可考虑输注。
- 失血性休克:建议红细胞、血浆和血小板比例2:1:1至1:1:1直至出血不再危及生命。
- 推荐未来研究开发生理和实验室指标以指导红细胞输注。
- 推荐未来研究确定目标导向止血复苏是否改善生存。
- 推荐未来研究确定低滴度O型全血是否比重组全血更有效和安全。
证据类型、等级与局限
- 证据类型:国际多学科专家共识会议(38名专家,出血亚组5名专家),采用RAND/UCLA适宜性方法和GRADE分级。
- 局限:原文未报告局限性
对床旁实践的改变
- 对非危及生命出血的危重患儿,血红蛋白<5 g/dL时推荐输注红细胞,5–7 g/dL时可考虑输注。
- 对失血性休克的危重患儿,建议红细胞、血浆和血小板按2:1:1至1:1:1比例输注,直至出血不再危及生命。
- 作者推荐未来研究开发生理和实验室指标以指导红细胞输注需求。
- 作者推荐未来研究确定目标导向止血复苏是否改善生存。
- 作者推荐未来研究确定低滴度O型全血是否比重组全血更有效和安全。
指南或共识出处
- 儿童重症监护输血与贫血专家倡议(Pediatric Critical Care Transfusion and Anemia Expertise Initiative)共识会议
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To present the recommendations and supporting literature for RBC transfusions in critically ill children with bleeding developed by the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.
DESIGN: Consensus conference series of international, multidisciplinary experts in RBC transfusion management of critically ill children.
METHODS: The panel of 38 experts developed evidence-based and, when evidence was lacking, expert-based clinical recommendations as well as research priorities for RBC transfusions in critically ill children. The bleeding subgroup included five experts. Electronic searches were conducted using PubMed, EMBASE, and Cochrane Library databases from 1980 to May 2017. Agreement was obtained using the Research and Development/UCLA Appropriateness Method. Results were summarized using the Grading of Recommendations Assessment, Development, and Evaluation method.
RESULTS: Transfusion and Anemia Expertise Initiative Consensus Conference experts developed a total of six recommendations focused on transfusion in the critically ill child with acute bleeding. In critically ill children with nonlife-threatening bleeding, we recommend giving a RBC transfusion for a hemoglobin concentration less than 5 g/dL, and be considered for a hemoglobin concentration between 5 and 7 g/dL. In critically ill children with hemorrhagic shock, we suggest that RBCs, plasma and platelets transfusion ratio between 2:1:1 to 1:1:1 until the bleeding is no longer life-threatening. We recommend future studies to develop physiologic and laboratory measures to indicate the need for RBC transfusions, and to determine if goal directed hemostatic resuscitation improves survival. Finally, we recommend future studies to determine if low titer group O whole blood is more efficacious and safe compared with reconstituted whole blood in children with hemorrhagic shock.
CONCLUSIONS: The Transfusion and Anemia Expertise Initiative Consensus Conference developed pediatric specific recommendations regarding RBC transfusion management in the critically ill child with acute bleeding, as well as recommendations to help guide future research priorities.
参考来源
- Karam O, Russell RT, Stricker P, et al. Recommendations on RBC Transfusion in Critically Ill Children With Nonlife-Threatening Bleeding or Hemorrhagic Shock From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Pediatr Crit Care Med. 2018. PMID: 30161067. doi:10.1097/PCC.0000000000001605
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。